← Leaderboards
Amany M Tawfik
Oakland University
$1,833,429
Attributed
$1,833,429
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $383.4K · FY2019–23$500K$375K$250K$125K$0
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$1,833,429 · 1
By mechanism
R01$1,833,429 · 1
Top collaborators
No co-investigators on record.
Most similar at Oakland University
Same institution · by research overlap
- Kenneth Patrick Mitton$1,812,096
Others in their field
Other Emerging Leaders on “Functional Disorder”
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,315,120
- Beth Baseler · Leidos Biomedical Research, Inc.$87,027,148
- Susan M Landau · University Of California Berkeley$47,252,026
- Evan Z Macosko · Broad Institute, Inc.$28,495,187
- Christopher Barnaby Nelson · University Of Melbourne$27,954,628
- Barbara Halina Braffett · George Washington University$22,016,904
Research focus
Functional DisorderAmino AcidsAgingFolic Acid SupplementationBloodCellsChoroidal NeovascularizationBevacizumabBlindnessAge Related Macular DegenerationDietary SupplementationElderlyElectric ImpedanceEndothelial CellsEndotheliumEnzymesEvaluationExhibitsExperimental ModelsExperimental StudyFluorescein AngiographyFluorescein Isothiocyanate DextranFolic AcidGene Therapy
Grant awards (6)
Homocysteine's role in Age-Related Macular Degeneration$362,363
R01 · FY2023 · EY · contact PI
Homocysteine's role in Age-Related Macular Degeneration$360,490
R01 · FY2022 · EY · contact PI
Homocysteine's role in Age-Related Macular Degeneration$253,391
R01 · FY2021 · EY · contact PI
Homocysteine's role in Age-Related Macular Degeneration$120,059
R01 · FY2021 · EY · contact PI
Homocysteine's role in Age-Related Macular Degeneration$383,438
R01 · FY2020 · EY · contact PI
Homocysteine's role in Age-Related Macular Degeneration$353,688
R01 · FY2019 · EY · contact PI